RESUMO
The innate immune receptor RIG-I recognizes 5'-triphosphate double-stranded RNAs (5' PPP dsRNA) as pathogenic RNAs. Such RNA-ends are present in viral genomes and replication intermediates, and they activate the RIG-I signaling pathway to produce a potent interferon response essential for viral clearance. Endogenous mRNAs cap the 5' PPP-end with m7G and methylate the 2'-O-ribose to evade RIG-I, preventing aberrant immune responses deleterious to the cell. Recent studies have identified RNAs in cells capped with metabolites such as NAD+, FAD and dephosphoCoA. Whether RIG-I recognizes these metabolite-capped RNAs has not been investigated. Here, we describe a strategy to make metabolite-capped RNAs free from 5' PPP dsRNA contamination, using in vitro transcription initiated with metabolites. Mechanistic studies show that metabolite-capped RNAs have a high affinity for RIG-I, stimulating the ATPase activity at comparable levels to 5' PPP dsRNA. Cellular signaling assays show that the metabolite-capped RNAs potently stimulate the innate antiviral immune response. This demonstrates that RIG-I can tolerate diphosphate-linked, capped RNAs with bulky groups at the 5' RNA end. This novel class of RNAs that stimulate RIG-I signaling may have cellular roles in activating the interferon response and may be exploited with proper functionalities for RIG-I-related RNA therapeutics.
Assuntos
RNA Helicases DEAD-box , RNA de Cadeia Dupla , Proteína DEAD-box 58/genética , RNA Helicases DEAD-box/metabolismo , Imunidade Inata , Interferons/genética , Ligantes , Capuzes de RNA , RNA Viral/genética , RNA Viral/metabolismo , Transdução de Sinais , HumanosRESUMO
Parkinson's disease (PD) is a multifactorial malady and the second most common neurodegenerative disorder, characterized by loss of dopaminergic neurons in the midbrain. A hallmark of PD pathology is the formation of intracellular protein inclusions, termed Lewy bodies (LBs). Recent MS studies have shown that OTU deubiquitinase ubiquitin aldehyde-binding 1 (OTUB1), a deubiquitinating enzyme of the OTU family, is enriched together with α-synuclein in LBs from individuals with PD and is also present in amyloid plaques associated with Alzheimer's disease. In the present study, using mammalian cell cultures and a PD mouse model, along with CD spectroscopy, atomic force microscopy, immunofluorescence-based imaging, and various biochemical assays, we demonstrate that after heat-induced protein aggregation, OTUB1 reacts strongly with both anti-A11 and anti-osteocalcin antibodies, detecting oligomeric, prefibrillar structures or fibrillar species of amyloidogenic proteins, respectively. Further, recombinant OTUB1 exhibited high thioflavin-T and Congo red binding and increased ß-sheet formation upon heat induction. The oligomeric OTUB1 aggregates were highly cytotoxic, characteristic of many amyloid proteins. OTUB1 formed inclusions in neuronal cells and co-localized with thioflavin S and with α-synuclein during rotenone-induced stress. It also co-localized with the disease-associated variant pS129-α-synuclein in rotenone-exposed mouse brains. Interestingly, OTUB1 aggregates were also associated with severe cytoskeleton damage, rapid internalization inside the neuronal cells, and mitochondrial damage, all of which contribute to neurotoxicity. In conclusion, the results of our study indicate that OTUB1 may contribute to LB pathology through its amyloidogenic properties.
Assuntos
Amiloide/química , Enzimas Desubiquitinantes/toxicidade , Neurotoxinas/toxicidade , Doença de Parkinson/patologia , Agregados Proteicos , Citoesqueleto de Actina/metabolismo , Animais , Apoptose/efeitos dos fármacos , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Simulação por Computador , Citoesqueleto/efeitos dos fármacos , Citoesqueleto/metabolismo , Enzimas Desubiquitinantes/química , Modelos Animais de Doenças , Endocitose/efeitos dos fármacos , Masculino , Camundongos Endogâmicos C57BL , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Modelos Biológicos , Nanoestruturas/química , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Oxirredução , Fosfosserina/metabolismo , Multimerização Proteica , Espécies Reativas de Oxigênio/metabolismo , Rotenona , alfa-Sinucleína/metabolismoRESUMO
Protein post-translational modification by ubiquitin represents a complex signaling system that regulates many cellular events including proteostasis to intercellular communications. Deubiquitinating enzymes (DUBs) that specifically disassemble Ub-chains or regulate ubiquitin homeostasis reside as a central component in ubiquitin signaling. Human genome encodes almost 100 DUBs and majority of them are not well characterized. Considerable progress has been made in the understanding of enzymatic mechanism; however, their cellular substrate specificity and regulation are largely unknown. Involvement of DUBs in disease regulation has been depicted since its discovery and several attempts have been made for evaluating DUBs as a drug target. In this review, we have updated briefly a new insight of DUBs activity, their cellular role, disease regulation, and therapeutic potential.
Assuntos
Enzimas/metabolismo , Neoplasias/metabolismo , Células-Tronco/metabolismo , Ubiquitina/metabolismo , Dano ao DNA , Reparo do DNA , Enzimas/química , Humanos , Doenças Neurodegenerativas/metabolismo , Oxirredução , Fosforilação , Processamento de Proteína Pós-Traducional , Proteínas Ribossômicas/metabolismo , Transdução de Sinais , Especificidade por Substrato , Sumoilação , Ubiquitinação , Ubiquitinas/metabolismoRESUMO
Amyloid formation drives the pathology of different neurodegenerative diseases. α-Synuclein is a natively unfolded protein that assembles itself into toxic amyloid structures, hence contributing to synucleinopathy. Its amyloid formation proceeds through various conformational intermediate stages, starting with a lag phase, followed by a rapid growth phase, and leading to beta rich fibril formation. Few studies have shown that the helix rich intermediate may be involved in fibril formation. Earlier, the helix intermediate was only studied in the membrane bound state. Despite many years of research, a precise mechanism of α-synuclein aggregation and the significance of intermediates with variable secondary structures are not well elucidated. Therefore, this study aims to understand the importance of secondary structures in α-synuclein-mediated neuronal toxicity. Our data revealed that the helix rich intermediate species exposes more of the hydrophobic surface than the beta rich intermediate species and harbors with the lipid membrane efficiently, thus contributing to the greater roughness of the cellular membrane that subsequently results in membrane disruption. It has been seen that upon internalization these species also activate the redox machinery. ß-Sheet enrichment contributes to self-assemblies of monomeric α-synuclein as it binds more with the monomeric species than the helix rich species. Additionally, we also observed that the beta rich species exhibits stronger TLR2 binding than the helix rich species as well as a potentiated neuroinflammatory cascade. Taken together, our data evidently put forward that secondary structures play a differential role during amyloid formation, and targeting them can be a novel intervention strategy for neurodegenerative disease progression.
Assuntos
Doenças Neurodegenerativas , alfa-Sinucleína , Amiloide , Humanos , Estrutura Secundária de Proteína , Receptor 2 Toll-LikeRESUMO
DJ-1 is a deglycase enzyme which exhibits a redox-sensitive chaperone-like activity. The partially oxidized state of DJ-1 is active in inhibiting the aggregation of α-synuclein, a key protein associated with Parkinson's disease. The underlying molecular mechanism behind α-synuclein aggregation inhibition remains unknown. Here we report that the partially oxidized DJ-1 possesses an adhesive surface which sequesters α-synuclein monomers and blocks the early stages of α-synuclein aggregation and also restricts the elongation of α-synuclein fibrils. DJ-1 remodels mature α-synuclein fibrils into heterogeneous toxic oligomeric species. The remodeled fibers show loose surface topology due to a decrease in elastic modulus and disrupt membrane architecture, internalize easily and induce aberrant nitric oxide release. Our results provide a mechanism by which partially oxidized DJ-1 counteracts α-synuclein aggregation at initial stages of aggregation and provide evidence of a deleterious effect of remodeled α-synuclein species generated by partially oxidized DJ-1.
Assuntos
Proteína Desglicase DJ-1/metabolismo , alfa-Sinucleína/metabolismo , Adesividade , Amiloide/química , Amiloide/metabolismo , Linhagem Celular , Módulo de Elasticidade , Humanos , Técnicas In Vitro , Microscopia de Força Atômica , Modelos Moleculares , Chaperonas Moleculares/química , Chaperonas Moleculares/metabolismo , Neurotoxinas/química , Neurotoxinas/metabolismo , Oxirredução , Doença de Parkinson/etiologia , Doença de Parkinson/metabolismo , Agregados Proteicos , Proteína Desglicase DJ-1/química , alfa-Sinucleína/químicaRESUMO
BRCA1-associated protein 1 (BAP1) is a nuclear localizing UCH, having tumor suppressor activity and is widely involved in many crucial cellular processes. BAP1 has garnered attention for its links with cancer, however, the molecular mechanism in the regulation of cancer by BAP1 has not been established. Amongst the four UCHs, only BAP1 and UCHL5 are able to hydrolyze small and large ubiquitin adducts but UCHL5 hydrolyzes only when it is present in the PA700 complex of the proteasome. The ability of BAP1 to cleave large ubiquitin derivatives is because of its relatively longer active-site crossover loop than other UCHs. The mechanism of ubiquitin recognition has not been studied for BAP1. The comparative enzymatic analysis of ubiquitin C-terminal hydrolase L1 (UCHL1), ubiquitin C-terminal hydrolase L3 (UCHL3), ubiquitin C-terminal hydrolase L5 (UCHL5N), and BAP1N has confirmed that enzymatically BAP1 is similar to UCHL5, which corroborates with the bioinformatics analysis done earlier. We have undertaken extensive mutational approaches to gain mechanistic insight into BAP1-ubiquitin interaction. Based on the homology-modeled BAP1 structure, we have identified a few BAP1 residues which possibly play a crucial role in ubiquitin interaction of which a few mutations have been identified in many cancers. Our comparative thermodynamic analysis reveals that BAP1-ubiquitin interaction is majorly driven by entropy factor which is unique amongst UCHs. Our study sheds light on BAP1 interaction with ubiquitin, which will be useful in understanding its enzymatic function.
Assuntos
Neoplasias/genética , Conformação Proteica , Proteínas Supressoras de Tumor/genética , Ubiquitina Tiolesterase/genética , Ubiquitina/genética , Cisteína Endopeptidases/genética , Humanos , Mutação , Neoplasias/patologia , Complexo de Endopeptidases do Proteassoma/química , Complexo de Endopeptidases do Proteassoma/genética , Homologia Estrutural de Proteína , Termodinâmica , Proteínas Supressoras de Tumor/química , Ubiquitina/química , Ubiquitina Tiolesterase/químicaRESUMO
Ubiquitin C-terminal Hydrolase-1 (UCHL1) is a deubiquitinating enzyme, which plays a key role in Parkinson's disease (PD). It is one of the most important proteins, which constitute Lewy body in PD patient. However, how this well folded highly soluble protein presents in this proteinaceous aggregate is still unclear. We report here that UCHL1 undergoes S-nitrosylation in vitro and rotenone induced PD mouse model. The preferential nitrosylation in the Cys 90, Cys 152 and Cys 220 has been observed which alters the catalytic activity and structural stability. We show here that nitrosylation induces structural instability and produces amorphous aggregate, which provides a nucleation to the native α-synuclein for faster aggregation. Our findings provide a new link between UCHL1-nitrosylation and PD pathology.
Assuntos
Doença de Parkinson Secundária/genética , Agregação Patológica de Proteínas/genética , Ubiquitina Tiolesterase/genética , alfa-Sinucleína/química , Animais , Humanos , Camundongos , Doença de Parkinson Secundária/induzido quimicamente , Doença de Parkinson Secundária/patologia , Rotenona/toxicidade , Ubiquitina Tiolesterase/química , alfa-Sinucleína/genéticaRESUMO
Emergence of antimicrobial resistant Gram-negative bacteria has created a serious global health crisis and threatens the effectiveness of most, if not all, antibiotics commonly used to prevent and treat bacterial infections. There is a dearth of detailed studies on the prevalence of antimicrobial resistance (AMR) patterns in India. Here, we have isolated and examined AMR patterns of 654 enteric pathogens and investigated complete genome sequences of isolates from six representative genera, which in aggregate encode resistance against 22 antibiotics representing nine distinct drug classes. This study revealed that ~97% isolates are resistant against ≥2 antibiotics, ~24% isolates are resistant against ≥10 antibiotics and ~3% isolates are resistant against ≥15 antibiotics. Analyses of whole genome sequences of six extensive drug resistant enteric pathogens revealed presence of multiple mobile genetic elements, which are physically linked with resistance traits. These elements are therefore appearing to be responsible for disseminating drug resistance among bacteria through horizontal gene transfer. The present study provides insights into the linkages between the resistance patterns to certain antibiotics and their usage in India. The findings would be useful to understand the genetics of resistance traits and severity of and difficulty in tackling AMR enteric pathogens.
Assuntos
Farmacorresistência Bacteriana/efeitos dos fármacos , Resistência a Múltiplos Medicamentos/genética , Microbioma Gastrointestinal/genética , Antibacterianos/farmacologia , Bactérias/genética , Infecções Bacterianas/tratamento farmacológico , Farmacorresistência Bacteriana Múltipla/genética , Microbioma Gastrointestinal/efeitos dos fármacos , Bactérias Gram-Negativas/efeitos dos fármacos , Humanos , Índia , Testes de Sensibilidade Microbiana , Fenótipo , Sequenciamento Completo do GenomaRESUMO
BRCA1 associated protein 1 (BAP1) is a nuclear deubiquitinase that regulates tumor suppressor activity and widely involves many cellular processes ranging from cell cycle regulation to gluconeogenesis. Impairment of enzymatic activity and nuclear localization induce abnormal cell proliferation. It is considered to be an important driver gene, which undergoes frequent mutations in several cancers. However the role of mutation and oncogenic gain of function of BAP1 are poorly understood. Here, we investigated cellular localization, enzymatic activity and structural changes for four missense mutants of the catalytic domain of BAP1, which are prevalent in different types of cancer. These mutations triggered cytoplasmic/perinuclear accumulation in BAP1 deficient cells, which has been observed in proteins that undergo aggregation in cellular condition. Amyloidogenic activity of mutant BAP1 was revealed from its reactivity towards anti oligomeric antibody in HEK293T cells. We have also noted structural destabilization in the catalytic domain mutants, which eventually produced beta amyloid structure as indicated in atomic force microscopy study. The cancer associated mutants up-regulate heat shock response and activates transcription of genes normally co-repressed by BAP1. Overall, our results unambiguously demonstrate that structural destabilization and subsequent aggregation abrogate its cellular mechanism leading to adverse outcome.